NovaBay Pharmaceuticals, Inc. (NBY)
NYSEAMERICAN: NBY · Real-Time Price · USD
1.220
-0.170 (-12.23%)
Mar 9, 2026, 1:38 PM EDT - Market open
NovaBay Pharmaceuticals Analyst Ratings
Total Analysts
n/a
Consensus Rating
n/a
Price Target
n/a
Upside
n/a
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $40 → $4.25 | Strong Buy | Maintains | $40 → $4.25 | +248.36% | Nov 11, 2024 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Maintains $26,031 → $24,500 | Strong Buy | Maintains | $26,031 → $24,500 | +2,008,096.72% | May 20, 2022 |
| Roth Capital | Roth Capital | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Mar 26, 2018 |
| Roth Capital | Roth Capital | Strong Buy Initiates $193 | Strong Buy | Initiates | $193 | +15,678.69% | Jun 5, 2017 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Initiates $344,531 | Strong Buy | Initiates | $344,531 | +28,240,166.39% | Mar 6, 2013 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Initiates $344,531 | Strong Buy | Initiates | $344,531 | +28,240,166.39% | Mar 5, 2013 |